Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 866 entries
View as:

Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01908010 Org: User:
Start: 07/31/13 End: 11/30/13 Due: 11/30/14

A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03785184 Org: User:
Start: 04/29/19 End: 08/22/19 Due: 08/22/20

A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Budigalimab in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Phase: N/A Priority: Normal
NCT ID: NCT06772623 Org: User:
Start: 03/06/25 End: 11/30/27 Due: 11/30/28

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT03823391 Org: User:
Start: 03/27/19 End: 08/26/20 Due: 08/26/21

Study of AGN-151586 in Japanese Participants With Moderate to Severe Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT06151561 Org: User:
Start: 01/05/24 End: 04/03/24 Due: 04/03/25

A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece

Phase: N/A Priority: Normal
NCT ID: NCT05317494 Org: User:
Start: 05/26/22 End: 12/31/26 Due: 12/31/27

A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222

Phase: N/A Priority: Normal
NCT ID: NCT03969888 Org: User:
Start: 12/11/19 End: 06/09/22 Due: 06/09/23

RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

Phase: N/A Priority: Normal
NCT ID: NCT04832724 Org: User:
Start: 02/22/21 End: 03/18/24 Due: 03/18/25

A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06399718 Org: User:
Start: 04/30/24 End: 01/31/26 Due: 01/31/27

Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT02282982 Org: User:
Start: 10/31/14 End: 05/31/15 Due: 05/31/16

A Study to Assess the Pharmacokinetics and Safety of Co-administered Oral Galicaftor, Navocaftor, and ABBV-576 in Healthy Adults for the Treatment of Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT05530278 Org: User:
Start: 09/20/22 End: 11/29/22 Due: 11/29/23

Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)

Phase: N/A Priority: Normal
NCT ID: NCT04799353 Org: User:
Start: 03/15/21 End: 10/11/22 Due: 10/11/23

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Phase: N/A Priority: Normal
NCT ID: NCT07024784 Org: User:
Start: 07/15/25 End: 01/31/28 Due: 01/31/29

[11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT02606630 Org: User:
Start: 10/31/15 End: 12/31/15 Due: 12/31/16

An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05827887 Org: User:
Start: 06/25/23 End: 09/30/25 Due: 09/30/26

A Real-world Study to Assess Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Adult Participants With Diabetic Macular Edema in China

Phase: N/A Priority: Normal
NCT ID: NCT06548568 Org: User:
Start: 11/13/24 End: 05/31/27 Due: 05/31/28

A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT02167945 Org: User:
Start: 06/12/14 End: 05/13/21 Due: 05/13/22

A Study to Assess Food Effect of Venetoclax New Tablet Formulation in Healthy Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT06070948 Org: User:
Start: 10/05/23 End: 07/28/25 Due: 07/28/26

A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

Phase: N/A Priority: Normal
NCT ID: NCT06333860 Org: User:
Start: 05/10/24 End: 03/31/26 Due: 03/31/27

A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

Phase: N/A Priority: Normal
NCT ID: NCT04274894 Org: User:
Start: 05/12/20 End: 01/07/22 Due: 01/07/23

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06972446 Org: User:
Start: 06/20/25 End: 11/30/27 Due: 11/30/28

A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04102020 Org: User:
Start: 03/26/20 End: 06/30/26 Due: 06/30/27

ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars

Phase: N/A Priority: Normal
NCT ID: NCT05995340 Org: User:
Start: 11/21/23 End: 08/31/26 Due: 08/31/27

Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis

Phase: N/A Priority: Normal
NCT ID: NCT04451720 Org: User:
Start: 07/20/20 End: 11/21/22 Due: 11/21/23

A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT03926169 Org: User:
Start: 06/03/19 End: 08/02/21 Due: 08/02/22